Back
Top 25%
23.6%
Top 0.1%
12.5%
Top 19%
9.5%
#1
6.8%
#1
6.3%
Top 26%
4.1%
Top 10%
2.1%
Top 2%
2.1%
Top 0.7%
2.1%
Top 6%
2.1%
Top 33%
1.4%
Top 12%
1.4%
Top 8%
1.2%
Top 5%
1.2%
Top 1%
1.0%
Top 5%
1.0%
Top 0.8%
0.8%
Top 20%
0.8%
Top 32%
0.8%
Top 21%
0.8%
Top 29%
0.8%
Top 10%
0.5%
Incentivizing Narrow-Spectrum Antibiotics Development with Refunding
2020-07-15
health economics
Title + abstract only
View on medRxiv
Show abstract
The rapid rise of antibiotic resistance is a serious threat to global public health. Without further incentives, pharmaceutical companies have little interest in developing antibiotics, since the success probability is low and development costs are huge. The situation is exacerbated by the "antibiotics dilemma": Developing narrow-spectrum antibiotics against resistant bacteria is most beneficial for society, but least attractive for companies since their usage is more limited than for broad-spec...
Predicted journal destinations
1
PLOS ONE
1737 training papers
2
Proceedings of the National Academy of Sciences
100 training papers
3
Scientific Reports
701 training papers
4
Royal Society Open Science
49 training papers
5
Bulletin of Mathematical Biology
17 training papers
6
Nature Communications
483 training papers
7
BMC Medicine
155 training papers
8
Journal of The Royal Society Interface
54 training papers
9
Journal of Theoretical Biology
29 training papers
10
PLOS Computational Biology
141 training papers
11
eLife
262 training papers
12
Journal of Medical Internet Research
81 training papers
13
Epidemics
96 training papers
14
Infectious Disease Modelling
50 training papers
15
Malaria Journal
23 training papers
16
BMC Health Services Research
43 training papers
17
Mathematical Biosciences
15 training papers
18
npj Digital Medicine
85 training papers
19
Frontiers in Public Health
135 training papers
20
PLOS Medicine
95 training papers
21
BMC Public Health
148 training papers
22
Communications Medicine
63 training papers